The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)

Stopped early

Conditions studied: Parkinson's Disease

In brief

To determine the long-term consequences (8 years) of initiating patients with Parkinson's disease on either pramipexole or levodopa. We hypothesize that patients initiating therapy with pramipexole compared with levodopa will demonstrate less self-reported disability as measured by the Modified Schwab and England (S/E) scale 8 years after randomization.

Key facts

Study ID

NCT00804479

Run by

University of Rochester

People needed

222

Starts

2002-01-01

Expected to finish

2004-03-01

Last updated by the study team

2016-01-21

Who can join

Age: any. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Available 301 subjects enrolled in the CALM-PD study.

You may not qualify if…

• Those not enrolled in the CALM-PD study.

Where it is running

• University of Rochester — Rochester, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.